Holen Sie sich die Stockscreener-App
79.61
1.01%
-0.8138
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Lantheus Holdings (LNTH) Is Up 5.4% After New PYLARIFY TruVu And LUTATHERA ApprovalsHas The Bull Case Changed? - simplywall.st
Why Lantheus (LNTH) Is Up 5.4% After Dual FDA Wins In Radiopharmaceutical Oncology Expansion - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Lantheus Stock Analysis: 57% Gain Amid Revenue and Margin ConcernsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance UK
WINTON GROUP Ltd Grows Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus at Leerink Conference: Strategic Shifts and Challenges - Investing.com Nigeria
Why Lantheus Holdings stock popped by almost 12% last month - MSN
Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com
Lantheus Holdings Inc (LNTH) Stock Price Up 7.21% on Mar 9 - GuruFocus
Lantheus (NASDAQ:LNTH) Trading 7.2% HigherTime to Buy? - MarketBeat
Citizens reiterates Lantheus stock rating on royalty opportunities By Investing.com - Investing.com Canada
Why Is LNTH Stock Up After Hours? - Stocktwits
(LNTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out - ACCESS Newswire
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out | NDAQ:LNTH | Press Release - Stockhouse
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging By Investing.com - Investing.com Australia
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com Nigeria
Teachers Retirement System of The State of Kentucky Reduces Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy - MarketBeat
American Century Companies Inc. Sells 341,642 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - Sahm
TD Cowen updates financial model citing upcoming Q4 results for Lantheus Holdings, Inc. (LNTH) - MSN
Lantheus (LNTH) Gains FDA Approval for New Prostate Cancer Imagi - GuruFocus
Lantheus Announces FDA Approval of PYLARIFY TruVu (piflufolastat F 18) Injection - Finviz
Lantheus Announces FDA Approval of PYLARIFY TruVu™, a New Formulation of Its PSMA PET Imaging Agent to Enhance Patient Access and Supply Capacity - Quiver Quantitative
Lantheus announces FDA approval of Pylarify TruVu (piflufolastat F 18) injection - marketscreener.com
US FDA approves Lantheus' new prostate cancer imaging formulation - Reuters
FDA OKs new PYLARIFY TruVu scan to expand prostate cancer imaging - Stock Titan
Heron Bay Capital Management Acquires New Shares in Lantheus Holdings, Inc. $LNTH - MarketBeat
Elo Mutual Pension Insurance Co Acquires New Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Bets On TruVu To Keep PYLARIFY Growing - Finimize
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Reach Out - ACCESS Newswire
Quantbot Technologies LP Makes New Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat
Equity award, tax share disposition for Lantheus (LNTH) officer - Stock Titan
Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan
Lantheus Holdings (LNTH) CFO nets PSU award, withholds shares for taxes - Stock Titan
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada
Lantheus Holdings (LNTH): Analyst Raises Price Target to $89 | L - GuruFocus
Lantheus (LNTH) Secures FDA Tentative Nod for New Cancer Treatme - GuruFocus
Lantheus Says US FDA Tentatively Approves PNT2003 - marketscreener.com
Lantheus receives FDA tentative approval for generic cancer drug - Investing.com India
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® - The Manila Times
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential - DirectorsTalk Interviews
Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook - Yahoo Finance
Lantheus Holdings, Inc. $LNTH Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Lantheus Holdings (LNTH) Net Margin Decline Tests Bullish Earnings Growth Narrative - Sahm
TD Asset Management Inc Increases Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Dana Investment Advisors Inc. Sells 13,875 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
A Look At Lantheus Holdings (LNTH) Valuation After Q4 Beat And Cautious 2026 Guidance - simplywall.st
Seaport Global Upgrades LNTH to Neutral Feb 27, 2026 Lantheus Holdings, Inc - Meyka
Lantheus (NASDAQ:LNTH) Price Target Raised to $85.00 at Mizuho - MarketBeat
LNTH: Mizuho Raises Price Target to $85, Maintains Outperform Ra - GuruFocus
Truist Securities Adjusts Lantheus Holdings PT to $89 From $82, Maintains Buy Rating - marketscreener.com
LNTH: 2025 Earnings Flash Report - Zacks Small Cap Research
Citizens Analyst Raises Lantheus Holdings (LNTH) Price Target to $85.00 | LNTH Stock News - GuruFocus
Lantheus (NASDAQ:LNTH) Given "Hold" Rating at JonesTrading - MarketBeat
Lantheus Holdings (LNTH) Downgraded to Hold by Jones Trading | L - GuruFocus
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2025 Earnings Call Transcript - Insider Monkey
0.86%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):